WRN-IN-23
WRN-IN-23 is a Werner Syndrome helicase enzyme (WRN) inhibitor. WRN-IN-23 inhibits the ATP-dependent helicase domain activity of WRN. WRN-IN-23 can be used for the research of cancers characterized by microsatellite instability (MSI) and/or defective DNA mismatch repair system (dMMR).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2923008-65-3
- Formel: C16H20N2O4S
- Molecular Weight:336.41
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle DNA/RNA Synthesis Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
Helicase |
WRN-IN-23 shows a pIC50 of 6-7 for WRN[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 2923008-65-3
-
Molecular Weight 336.41
-
Formel C16H20N2O4S
-
SMILES
O=C1NC(C2CCCCC2)=CC=C1C(N[C@H]3C=CS(=O)(C3)=O)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)